CHEMOMETEC Lifts Profit to DKK 201.8M and Guides for Faster Growth
The Danish cell-counting specialist grew revenue 3% to DKK 511.1 million in 2025/26 and expects DKK 545-575 million in the new financial year.
The Danish cell-counting specialist grew revenue 3% to DKK 511.1 million in 2025/26 and expects DKK 545-575 million in the new financial year.
Tadaa Technology will supply the AI backbone for a 1,000-acre solar farm feeding a data centre under a 25-year power arrangement, targeting $7.3M in annual revenue.
Alpha Compute has signed definitive agreements for Utica and Marcellus acreage with more than 75 wells, and plans to build a data center on the site.
Palisade Bio can start the Phase 2 ASCENTRA-CD trial of its oral PDE4 prodrug, with first dosing targeted for Q1 2027 and a primary readout in Q1 2028.
VERSATILE-002 results for PDS0101 plus pembrolizumab show 39.3 months median overall survival in checkpoint-inhibitor-naive HPV16-positive head and neck cancer.